Ludwig Enterprises, Inc. has announced a significant change in control following a recent stock purchase agreement with FOXO Technologies Inc. On October 25, 2026, the company reported that the Thomas E. Terwilliger Revocable Trust and Vasaio Capital, Inc. entered into agreements to sell a total of 5,000,000 shares of Series A Convertible Preferred Stock to FOXO. This change is crucial as it grants FOXO substantial voting power within Ludwig Enterprises, potentially reshaping the company's future direction.

This development is particularly relevant for Ludwig Enterprises, which operates in the medical laboratories sector. As the industry evolves, competitors may need to reassess their strategies in light of this new control structure. The filing indicates that FOXO now holds approximately 57.7% of Ludwig's total voting power, significantly influencing decision-making processes.

Background

Ludwig Enterprises, Inc. is classified under the Standard Industrial Classification (SIC) code 8071, which pertains to services in medical laboratories. The company is listed under the ticker symbol LUDG on the OTC exchange. The recent filing, dated November 2, 2026, marks a pivotal moment for the company following its previous filings, including an 8-K on October 6, 2026, and a Schedule 13D on October 29, 2026.

What the Filing Says

The SEC filing details that the stock purchase agreements allow FOXO to acquire significant control over Ludwig Enterprises. The filing states, "As a result of the Proxies, a change in control of the Company occurred on October 25, 2026, with control passing from the Selling Holders to FOXO." This transition indicates a shift in governance and strategic direction for Ludwig.

Impact

The change in control may affect various stakeholders, including shareholders, employees, and competitors within the medical laboratories sector. The Board of Directors of Ludwig has been informed of these transactions and is currently evaluating their implications. The filing notes that the Board continues to explore strategic alternatives available to the company, signaling potential changes in operations or business strategy.

What's Next

The filing does not specify what happens next regarding the ongoing evaluation by the Board of Directors or any potential future filings. However, it does indicate that the Board will continue to assess the situation and may disclose further developments as appropriate.